09/09/2024 | Press release | Distributed by Public on 09/09/2024 15:11
|
ABOUT THIS PROSPECTUS SUPPLEMENT
|
| | | | S-1 | | |
|
PROSPECTUS SUPPLEMENT SUMMARY
|
| | | | S-2 | | |
|
RISK FACTORS
|
| | | | S-4 | | |
|
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | S-4 | | |
|
USE OF PROCEEDS
|
| | | | S-6 | | |
|
SELLING STOCKHOLDER
|
| | | | S-7 | | |
|
PLAN OF DISTRIBUTION
|
| | | | S-8 | | |
|
LEGAL MATTERS
|
| | | | S-10 | | |
|
EXPERTS
|
| | | | S-10 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | S-11 | | |
|
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
|
| | | | S-12 | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 2 | | |
|
INCORPORATION BY REFERENCE
|
| | | | 2 | | |
|
RISK FACTORS
|
| | | | 4 | | |
|
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 4 | | |
|
PROSPECTUS SUMMARY
|
| | | | 6 | | |
|
USE OF PROCEEDS
|
| | | | 7 | | |
|
DESCRIPTION OF SECURITIES
|
| | | | 7 | | |
|
DESCRIPTION OF CAPITAL STOCK AND OUTSTANDING WARRANTS
|
| | | | 7 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 14 | | |
|
DESCRIPTION OF WARRANTS
|
| | | | 23 | | |
|
DESCRIPTION OF RIGHTS
|
| | | | 25 | | |
|
DESCRIPTION OF UNITS
|
| | | | 25 | | |
|
SELLING STOCKHOLDERS
|
| | | | 26 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 27 | | |
|
LEGAL MATTERS
|
| | | | 31 | | |
|
EXPERTS
|
| | | | 31 | | |
| | |
Shares of Class A
Common Stock Beneficially Owned Prior to the Offering |
| |
Shares of
Class A Common Stock Being Offered(1) |
| |
Shares of Class A
Common Stock Beneficially Owned After the Offering(2) |
| |||||||||||||||||||||
Name of Selling Stockholder
|
| |
Number
|
| |
Percentage
|
| |
Number
|
| |
Number
|
| |
Percentage
(%) |
| |||||||||||||||
Nivagen Pharmaceuticals, Inc.
3050 Fite Cir, Suite 100 Sacramento, CA 95827 |
| | | | 976,341 | | | | | | * | | | | | | 976,341 | | | | | | - | | | | | | - | | |
| | |
Page
|
| |||
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 2 | | |
INCORPORATION BY REFERENCE
|
| | | | 2 | | |
RISK FACTORS
|
| | | | 4 | | |
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 4 | | |
PROSPECTUS SUMMARY
|
| | | | 6 | | |
USE OF PROCEEDS
|
| | | | 7 | | |
DESCRIPTION OF SECURITIES
|
| | | | 7 | | |
DESCRIPTION OF CAPITAL STOCK AND OUTSTANDING WARRANTS
|
| | | | 7 | | |
DESCRIPTION OF DEBT SECURITIES
|
| | | | 14 | | |
DESCRIPTION OF WARRANTS
|
| | | | 23 | | |
DESCRIPTION OF RIGHTS
|
| | | | 25 | | |
DESCRIPTION OF UNITS
|
| | | | 25 | | |
SELLING STOCKHOLDERS
|
| | | | 26 | | |
PLAN OF DISTRIBUTION
|
| | | | 27 | | |
LEGAL MATTERS
|
| | | | 31 | | |
EXPERTS
|
| | | | 31 | | |